dc.contributor.author |
Hetrick, Sarah |
en |
dc.contributor.author |
Meader, N |
en |
dc.contributor.author |
Bailey, AP |
en |
dc.contributor.author |
Badcock, PB |
en |
dc.contributor.author |
Moller, CI |
en |
dc.contributor.author |
Cox, GR |
en |
dc.contributor.author |
Merry, Sally |
en |
dc.contributor.author |
McKenzie, JE |
en |
dc.date.accessioned |
2020-08-18T22:54:21Z |
en |
dc.date.issued |
2020-07-09 |
en |
dc.identifier.citation |
Cochrane Database of Systematic Reviews 2020(7) 09 Jul 2020 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/52698 |
en |
dc.description.abstract |
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To investigate, via network meta-analyses (NMA), the comparative effectiveness and safety of different newer generation antidepressants in children and adolescents with a diagnosed major depressive disorder (MDD). Specific objectives, in order of priority, are to:. estimate the relative effects of newer generation antidepressants compared with placebo and with each other on depression, functioning, suicide-related outcomes and other adverse outcomes; estimate the relative ranking of the included newer generation antidepressants for the outcomes of depression, functioning, suicide-related outcomes and other adverse outcomes; and, examine whether the relative effects on clinician-rated depression symptoms and suicide-related outcomes estimated in objectives 1 and 2 are modified by age, treatment duration, baseline severity and pharmaceutical industry funding of the antidepressant under evaluation. |
en |
dc.relation.ispartofseries |
Cochrane Database of Systematic Reviews |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights |
This Protocol of a Cochrane Review was published in the Cochrane Database of Systematic Reviews 2020, 7. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Protocol. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.rights.uri |
https://documentation.cochrane.org/display/EPPR/Standard+%7C+Protocol+for+a+Cochrane+Review |
en |
dc.title |
New generation antidepressants for depression in children and adolescents: a network meta-analysis |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1002/14651858.CD013674 |
en |
pubs.issue |
7 |
en |
pubs.volume |
2020 |
en |
dc.rights.holder |
Copyright: Cochrane Collaboration |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
809397 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Psychological Medicine Dept |
en |
dc.identifier.eissn |
1469-493X |
en |